company background image

Elevance Health NYSE:ELV Stock Report

Last Price


Market Cap







09 Aug, 2022


Company Financials +
ELV fundamental analysis
Snowflake Score
Future Growth1/6
Past Performance5/6
Financial Health6/6

ELV Stock Overview

Elevance Health Inc. operates as a health benefits company.

Elevance Health Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Elevance Health
Historical stock prices
Current Share PriceUS$483.97
52 Week HighUS$533.68
52 Week LowUS$355.43
1 Month Change-0.066%
3 Month Change-0.70%
1 Year Change28.25%
3 Year Change68.69%
5 Year Change150.78%
Change since IPO2,266.60%

Recent News & Updates

Aug 01
Elevance Health (NYSE:ELV) Shareholders Will Want The ROCE Trajectory To Continue

Elevance Health (NYSE:ELV) Shareholders Will Want The ROCE Trajectory To Continue

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Jul 20

Elevance Health declares $1.28 dividend

Elevance Health (NYSE:ELV) declares $1.28/share quarterly dividend, in line with previous. Forward yield 1.03% Payable Sept. 23; for shareholders of record Sept. 9; ex-div Sept. 8. See ELV Dividend Scorecard, Yield Chart, & Dividend Growth.

Jul 18
Do Elevance Health's (NYSE:ELV) Earnings Warrant Your Attention?

Do Elevance Health's (NYSE:ELV) Earnings Warrant Your Attention?

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Shareholder Returns

ELVUS HealthcareUS Market

Return vs Industry: ELV exceeded the US Healthcare industry which returned 13.5% over the past year.

Return vs Market: ELV exceeded the US Market which returned -13% over the past year.

Price Volatility

Is ELV's price volatile compared to industry and market?
ELV volatility
ELV Average Weekly Movement4.5%
Healthcare Industry Average Movement9.0%
Market Average Movement7.9%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.2%

Stable Share Price: ELV is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: ELV's weekly volatility (4%) has been stable over the past year.

About the Company

194498,200Gail Boudreaux

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.

Elevance Health Fundamentals Summary

How do Elevance Health's earnings and revenue compare to its market cap?
ELV fundamental statistics
Market CapUS$116.15b
Earnings (TTM)US$6.10b
Revenue (TTM)US$149.13b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ELV income statement (TTM)
Cost of RevenueUS$111.18b
Gross ProfitUS$37.96b
Other ExpensesUS$31.86b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)25.43
Gross Margin25.45%
Net Profit Margin4.09%
Debt/Equity Ratio65.8%

How did ELV perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio

Does ELV pay a reliable dividends?

See ELV dividend history and benchmarks
When do you need to buy ELV by to receive an upcoming dividend?
Elevance Health dividend dates
Ex Dividend DateSep 08 2022
Dividend Pay DateSep 23 2022
Days until Ex dividend29 days
Days until Dividend pay date44 days

Does ELV pay a reliable dividends?

See ELV dividend history and benchmarks
We’ve recently updated our valuation analysis.


Is ELV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 5/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ELV?

Other financial metrics that can be useful for relative valuation.

ELV key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.9x
Enterprise Value/EBITDA13.6x
PEG Ratio1.8x

Price to Earnings Ratio vs Peers

How does ELV's PE Ratio compare to its peers?

ELV PE Ratio vs Peers
The above table shows the PE ratio for ELV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average25.4x
HUM Humana
CNC Centene
UNH UnitedHealth Group
MOH Molina Healthcare
ELV Elevance Health

Price-To-Earnings vs Peers: ELV is good value based on its Price-To-Earnings Ratio (19x) compared to the peer average (25.4x).

Price to Earnings Ratio vs Industry

How does ELV's PE Ratio compare vs other companies in the US Healthcare Industry?

Price-To-Earnings vs Industry: ELV is good value based on its Price-To-Earnings Ratio (19x) compared to the US Healthcare industry average (20.3x)

Price to Earnings Ratio vs Fair Ratio

What is ELV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ELV PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19x
Fair PE Ratio38.5x

Price-To-Earnings vs Fair Ratio: ELV is good value based on its Price-To-Earnings Ratio (19x) compared to the estimated Fair Price-To-Earnings Ratio (38.5x).

Share Price vs Fair Value

What is the Fair Price of ELV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ELV ($483.97) is trading below our estimate of fair value ($804.73)

Significantly Below Fair Value: ELV is trading below fair value by more than 20%.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Future Growth

How is Elevance Health forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?

Future Growth Score


Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ELV's forecast earnings growth (10.7% per year) is above the savings rate (1.9%).

Earnings vs Market: ELV's earnings (10.7% per year) are forecast to grow slower than the US market (14.6% per year).

High Growth Earnings: ELV's earnings are forecast to grow, but not significantly.

Revenue vs Market: ELV's revenue (6.9% per year) is forecast to grow slower than the US market (7.9% per year).

High Growth Revenue: ELV's revenue (6.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ELV's Return on Equity is forecast to be low in 3 years time (19.1%).

Discover growth companies

Past Performance

How has Elevance Health performed over the past 5 years?

Past Performance Score


Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: ELV has high quality earnings.

Growing Profit Margin: ELV's current net profit margins (4.1%) are higher than last year (3.3%).

Past Earnings Growth Analysis

Earnings Trend: ELV's earnings have grown by 11.3% per year over the past 5 years.

Accelerating Growth: ELV's earnings growth over the past year (44.3%) exceeds its 5-year average (11.3% per year).

Earnings vs Industry: ELV earnings growth over the past year (44.3%) exceeded the Healthcare industry 7.7%.

Return on Equity

High ROE: ELV's Return on Equity (16.9%) is considered low.

Discover strong past performing companies

Financial Health

How is Elevance Health's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: ELV's short term assets ($53.7B) exceed its short term liabilities ($39.3B).

Long Term Liabilities: ELV's short term assets ($53.7B) exceed its long term liabilities ($25.7B).

Debt to Equity History and Analysis

Debt Level: ELV has more cash than its total debt.

Reducing Debt: ELV's debt to equity ratio has reduced from 66.2% to 65.8% over the past 5 years.

Debt Coverage: ELV's debt is well covered by operating cash flow (38.9%).

Interest Coverage: ELV's interest payments on its debt are well covered by EBIT (10.9x coverage).

Balance Sheet

Discover healthy companies


What is Elevance Health current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 4/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Upcoming Dividend Payment

TodayAug 10 2022Ex Dividend DateSep 08 2022Dividend Pay DateSep 23 202215 days from Ex DividendBuy in the next 29 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: ELV's dividend (1.06%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.52%).

High Dividend: ELV's dividend (1.06%) is low compared to the top 25% of dividend payers in the US market (4.08%).

Stability and Growth of Payments

Stable Dividend: ELV's dividends per share have been stable in the past 10 years.

Growing Dividend: ELV's dividend payments have increased over the past 10 years.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (19.1%), ELV's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (15.3%), ELV's dividend payments are well covered by cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Gail Boudreaux (61 yo)





Ms. Gail Koziara Boudreaux has been an Independent Director at Target Corporation since September 23, 2021. She has been President, Chief Executive Officer and Director of Elevance Health Inc. (formerly kn...

CEO Compensation Analysis

Compensation vs Market: Gail's total compensation ($USD19.35M) is above average for companies of similar size in the US market ($USD12.91M).

Compensation vs Earnings: Gail's compensation has been consistent with company performance over the past year.

Leadership Team

Experienced Management: ELV's management team is seasoned and experienced (6.2 years average tenure).

Board Members

Experienced Board: ELV's board of directors are considered experienced (9 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: ELV insiders have only sold shares in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Elevance Health Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Elevance Health Inc.
  • Ticker: ELV
  • Exchange: NYSE
  • Founded: 1944
  • Industry: Managed Health Care
  • Sector: Healthcare
  • Implied Market Cap: US$116.153b
  • Shares outstanding: 240.00m
  • Website:

Number of Employees


  • Elevance Health Inc.
  • 220 Virginia Avenue
  • Indianapolis
  • Indiana
  • 46204
  • United States


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/09 00:00
End of Day Share Price2022/08/09 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.